Meeder Asset Management Inc Molecular Templates, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$9.99 - $14.41 $55,524 - $80,090	-5,558 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$12.28 - $17.63 $19,991 - $28,701	1,628 Added 41.42%	5,558 $77,000
Q1 2020 May 15, 2020	SELL	$11.31 - $18.26 $7,396 - $11,942	-654 Reduced 14.27%	3,930 $54,000
Q4 2019 Feb 13, 2020	BUY	$6.44 - $14.21 $14,702 - $32,441	2,283 Added 99.22%	4,584 $65,000
Q3 2019 Oct 17, 2019	SELL	$4.6 - $8.46 $18,722 - $34,432	-4,070 Reduced 63.88%	2,301 $15,000
Q2 2019 Aug 05, 2019	BUY	$5.83 - $8.42 $28,432 - $41,064	4,877 Added 326.44%	6,371 $53,000
Q1 2019 Apr 16, 2019	SELL	$4.02 - $5.81 $9,973 - $14,414	-2,481 Reduced 62.42%	1,494 $9,000
Q4 2018 Jan 17, 2019	BUY	$3.35 - $5.68 $7,282 - $12,348	2,174 Added 120.71%	3,975 $17,000
Q3 2018 Nov 02, 2018	BUY	$4.07 - $6.25 $7,330 - $11,256	1,801 New	1,801 $0

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $19.2M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.